Category: Diseases & Conditions
Europe Diseases & Conditions
-
Breast Tissue Markers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... biopsies and surgeries, ensuring accurate diagnosis and targeted treatment of breast cancer. According to market analysis, the global breast tissue markers market is expected to grow from US$ 3.3 billion in 2025 to US$ 6.1 ... Read More
-
Breast Recurrence Score Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... rate (CAGR) of 10.00% during the forecast period. Rising global breast cancer incidence, technological progress in genomic profiling, and the increasing preference for non-invasive diagnostic methods are driving the market forward. Market Insights Breast recurrence ... Read More
-
Global & Greece Cancer Therapeutics Market to 2031
... reported in 2022, with the disease causing more than 32,000 deaths. Among men, prostate, lung, and colorectal cancers are the most commonly diagnosed, while breast cancer leads among women, followed by colorectal and lung cancers. ... Read More
-
Global & Finland Cancer Therapeutics Market to 2031
... men; colorectal cancer affected both genders significantly. This rising cancer incidence has driven increased demand for innovative and effective treatment options. Leading research institutions such as the University of Helsinki, the Finnish Institute for Molecular ... Read More
-
Global & Luxembourg Cancer Therapeutics Market to 2031
... all yearly fatalities in the country. Luxembourg has become a key player in global cancer research and oncology, demonstrated by its substantial investment in research infrastructure, international collaborations, and development of scientific expertise. The nation ... Read More
-
Global & Norway Cancer Therapeutics Market to 2031
... In 2023, the Norwegian Cancer Society allocated approximately US$ 6.67 million (NOK 71 million) to researchers at the Faculty of Medicine (MED), highlighting its commitment to advancing cancer research in the country. Further reinforcing these ... Read More
-
Global & Czech Republic Cancer Therapeutics Market to 2031
... contributing to this increase include high alcohol consumption and a growing obese population. The government plays a crucial role in cancer management through the maintenance of the National Oncological Register (NOR), which helps track and ... Read More
-
Global & France Cancer Therapeutics Market to 2031
... of individuals aged 85 and older is projected to increase by nearly 90% between 2030 and 2050. This growing elderly population is a significant factor contributing to the expansion of the cancer therapeutics market, as ... Read More
-
Global & Portugal Cancer Therapeutics Market to 2031
... driving the demand for more advanced and effective treatment options. As the number of patients continues to grow, the cancer therapeutics market is expanding, with healthcare providers striving to improve access to life-saving therapies and ... Read More
-
Global & Spain Cancer Therapeutics Market to 2031
... demand for effective cancer therapies and improved patient care. The Spanish government actively promotes cancer awareness, supports innovation, and works to enhance access to advanced, life-saving treatments. On May 6, 2024, the European Cancer Organisation ... Read More
-
Global & Switzerland Cancer Therapeutics Market to 2031
... equating to roughly 377 cases per 100,000 people. The high incidence of cancer highlights the urgent need for effective treatment options in the country. In 2018, Switzerland joined forces with Australia, Canada, and Singapore to ... Read More
-
Global & Belgium Cancer Therapeutics Market to 2031
... incidence of cancer is driving increased demand for effective cancer treatments. As more patients seek care, healthcare providers are in need of innovative therapies to address various cancer types. In June 2024, Belgium introduced an ... Read More
-
Global & Bulgaria Cancer Therapeutics Market to 2031
... million euros, with approximately 69% of patients bearing out-of-pocket costs. Key risk factors such as smoking, poor dietary habits, and alcohol consumption contribute to the high prevalence of cancer in the country, with breast and ... Read More
-
Global & Denmark Cancer Therapeutics Market to 2031
... out of three individuals have a close family member affected by the disease. Projections indicate that between 2023 and 2050, cancer will account for 30% of all premature deaths (those occurring before age 75), translating ... Read More
-
Global & Netherlands Cancer Therapeutics Market to 2031
... enhancing cancer treatment and patient outcomes. In September 2024, the Dutch Research Council (NWO) allocated US$ 27.8 million (25 million euros) to tackle the rising challenges in cancer care. With the number of cancer patients ... Read More
-
Global & Slovakia Cancer Therapeutics Market to 2031
... alcohol consumption stands at 10 liters, exceeding the average across the European Union. Cancer screening rates are also below optimal levels; in 2023-2024, only about 25% of the eligible population underwent breast cancer screening, compared ... Read More
-
Global & United Kingdom Cancer Therapeutics Market to 2031
... by 2040.The emergence of immune checkpoint inhibitors has significantly transformed cancer treatment, offering renewed hope to patients. The UK also hosts Cancer Research UK, the world’s largest independent cancer charity. Each year, the organization allocates ... Read More
-
Global & Ukraine Cancer Therapeutics Market to 2031
... according to the World Health Organization. This figure is expected to rise in the coming years due to an aging population and the increasing prevalence of unhealthy lifestyle habits. As a result, there is a ... Read More
-
Global & Italy Cancer Therapeutics Market to 2031
... cancer being the most frequently diagnosed, accounting for 13.2% of all cases. This was followed by colorectal cancer at 12.6% and lung cancer at 10.0%. That same year, cancer-related deaths reached around 190,000. Contributing to ... Read More
-
Global & Poland Cancer Therapeutics Market to 2031
... the Polish National Cancer Registry reported around 171,558 new cancer diagnoses and 93,652 cancer-related deaths. Additionally, data from the Spanish Network of Cancer Registries indicates that around 8,805 breast cancer deaths occurred in Poland that ... Read More
-
Global & Romania Cancer Therapeutics Market to 2031
... the Romanian Ministry of Health reporting approximately 100,000 new diagnoses each year. The increasing prevalence of risk factors such as tobacco use, unhealthy diets, and an aging population continues to drive cancer incidence rates, thereby ... Read More
-
Global & Austria Cancer Therapeutics Market to 2031
... around 50,000 annual cases by 2030. By that same year, the total number of individuals living with cancer in the country is projected to reach 460,000—an increase of 15% compared to 2022. The most frequently ... Read More
-
Global & Germany Cancer Therapeutics Market to 2031
... Organization (WHO) indicates that in 2022, Germany registered approximately 630,000 new cancer cases and around 250,000 cancer-related deaths. This growing burden is driving a strong demand for more effective treatment options. Germany is also recognized ... Read More
-
Global & Sweden Cancer Therapeutics Market to 2031
... role in developing cutting-edge immuno-oncology therapies targeting cancers such as lung and bladder cancer. The Swedish government has taken proactive steps to strengthen its oncology sector through comprehensive national strategies. One such initiative, the Cancer ... Read More
-
Mitotane Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... to grow from a valuation of US$ 17.14 million in 2025 to US$ 24.2 million by the end of 2032, registering a CAGR of 5.05% over the forecast period from 2025 to 2032. Mitotane, a ... Read More
Research Assistance
